Details of the Drug
General Information of Drug (ID: DMNDS19)
Drug Name |
4-Flourobenzenesulfonamide
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
4-Fluorobenzenesulfonamide; 402-46-0; p-Fluorobenzenesulfonamide; 4-fluorobenzenesulphonamide; 4-fluorobenzene-1-sulfonamide; p-Fluorobenzenesulphonamide; 4-FLOUROBENZENESULFONAMIDE; EINECS 206-946-2; 4-fluoro-benzenesulfonamide; BRN 2832246; Benzenesulfonamide, p-fluoro-; Benzenesulfonamide, 4-fluoro-; PubChem2167; ACMC-1ACSJ; 4-Fuloro sulfonamide, C; 4-fluorobenzene sulfonamide; Cambridge id 5135296; AC1Q55BS; AC1L3QD2; 4-fluoranylbenzenesulfonamide; 4-fluoro benzene sulfonamide; Benzenesulfonamide,4-fluoro-; 4-11-00-00102 (Be
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 175.18 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 0.8 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 1 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||